Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Deorukhkar

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Cancer|September 22, 2011
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targetsAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2012
Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabineSahdeo Prasad, Vivek R Yadav, Bokyung Sung, et al.
Cancer Research|September 25, 2010
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironmentAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.
Nano Letters|April 17, 2008
Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategyParmeswaran Diagaradjane, Anil Shetty, James C Wang, et al.
Nanomedicine (London, England)|September 26, 2013
Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshellsWenxue Chen, Ciceron Ayala-Orozco, Nrusingh C Biswal, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Scientific Reports|February 15, 2019
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated RadiationJessica M Molkentine, Tara N Fujimoto, Thomas D Horvath, et al.
Molecular Cancer Therapeutics|May 6, 2010
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivoKuzhuvelil B Harikumar, Ajaikumar B Kunnumakkara, Nobuo Ochi, et al.
Gastroenterology|February 26, 2022
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer MicroenvironmentCarolina J Garcia Garcia, Yanqing Huang, Natividad R Fuentes, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Cancer|September 22, 2011
Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targetsAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2012
Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabineSahdeo Prasad, Vivek R Yadav, Bokyung Sung, et al.
Cancer Research|September 25, 2010
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironmentAjaikumar B Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, et al.
Nano Letters|April 17, 2008
Modulation of in vivo tumor radiation response via gold nanoshell-mediated vascular-focused hyperthermia: characterizing an integrated antihypoxic and localized vascular disrupting targeting strategyParmeswaran Diagaradjane, Anil Shetty, James C Wang, et al.
Nanomedicine (London, England)|September 26, 2013
Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshellsWenxue Chen, Ciceron Ayala-Orozco, Nrusingh C Biswal, et al.
JCI Insight|July 24, 2019
Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancerMeifang Yu, Nicholas D Nguyen, Yanqing Huang, et al.
Cancer Research|May 3, 2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic CancerTara N Fujimoto, Lauren E Colbert, Yanqing Huang, et al.
Scientific Reports|February 15, 2019
Enteral Activation of WR-2721 Mediates Radioprotection and Improved Survival from Lethal Fractionated RadiationJessica M Molkentine, Tara N Fujimoto, Thomas D Horvath, et al.
Molecular Cancer Therapeutics|May 6, 2010
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivoKuzhuvelil B Harikumar, Ajaikumar B Kunnumakkara, Nobuo Ochi, et al.
Gastroenterology|February 26, 2022
Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer MicroenvironmentCarolina J Garcia Garcia, Yanqing Huang, Natividad R Fuentes, et al.
Pageof 2